Relationships among Oxidation of Low-Density Lipoprotein, Antioxidant Protection, and Atherosclerosis

Advances in Pharmacology

Volumn 38, Issue C, 1996, Pages 425-456

  Esterbauer, Hermann ^a   Schmidt, Reinhold ^a   Hayn, Marianne ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956789933     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60994-1     Document Type: Article

References (150)

1. Abbey M., Nestel P.J., and Baghurst P.A. Antioxidant vitamins and low-density-lipoprotein oxidation. Am. J. Clin. Nutr. 58 (1993) 525-532
2. Alexander R.W. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: A new perspective. Hypertension 25 (1995) 155-161
3. Anderson T.W., and Reid W. A double-blind trial of vitamin E in the treatment of angina pectoris. Am. Heart J. 93 (1974) 444-449
4. ATBC Cancer Prevention Study Group. The alpha-tocopherol, beta-carotene lung cancer prevention study: Initial results from a controlled trial. N. Engl. J. Med. 330 (1994) 1029-1035
5. Autio I., Jaakkola O., Solakivi T., and Nikkari T. Oxidized low-density lipoprotein is chemotactic for arterial smooth muscle cells in culture. FEBS Lett. 277 (1990) 274-279
6. Badimon J.J., Fuster V., Chesobro J.H., and Badimon L. Coronary atherosclerosis: A multifactorial disease. Circulation 87 Suppl. II (1993) 3-16
7. Berliner J.A., Navab M., Fogelman A.M., Frank J.S., Demer L.L., Edwards P.A., Watson A.D., and Lusis A. Atherosclerosis: Basic mechanism, oxidation, inflammation, and genetics. Circulation 91 (1995) 2488-2496
8. Berliner J.A., Territo M.C., Sevanian A., Ramin S., Kim J.A., Ramshad B., Sterson M., and Fogelman A.M. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85 (1990) 1260-1266
9. Bieri J.G., Teets L., Beavady B., and Andrews E.L. Serum vitamin E levels in a normal adult population in the Washington, D.C., area. Proc. Soc. Exp. Biol. 117 (1964) 131-133
10. Block G., Patterson B., and Suhar A. Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence. Nutr. Cancer 18 (1992) 1-29
11. Blot W.J., Li J., Taylor P.R., Guo W., Dawsey S., Wang G., Yang C.S., Zheng S., Gail M., Li G., Yu Y., Liu B., Tangrea J., Sun Y., Liu F., Fraumeni J.F., Zhang Y., and Li B. Nutritional intervention trials in Linxian, China: Supplementation with specific vitamidmineral combinations, cancer incidence, and disease specific mortality in the general population. J. Natl. Cancer Inst. 85 (1993) 1483-1492
12. Bowry V.W., and Stocker R. Tocopherol-mediated peroxidation: The prooxidant effect of vitamin E on the radical initiated oxidation of human low-density lipoprotein. J. Am. Chem. Soc. 115 (1993) 6029-6044
13. Cazzolato G., Avogaro P., and Bittolo-Bon G. Characterization of a more electronegatively charged LDL subfraction by ion exchange HPLC. Free Rad. Bio. Med. 11 (1991) 247-253
14. Chait A., and Heinecke J.W. Lipoprotein modification: Cellular mechanisms. Curr. Opin. Lipid. 5 (1994) 365-370
15. Chen J., Geissler C., Parpia B., Li J., and Campbell T.C. Antioxidant status and cancer mortality in China. Int. J. Epidemiol. 21 (1992) 625-635
16. Chisolm G.M. The oxidation of lipoproteins: Implications for atherosclerosis. In: Spatz L., and Bloom A.D. (Eds). "Biological Consequences of Oxidative Stress: Implications for Cardiovascular Disease and Carcinogenesis" (1992), Oxford Univ. Press, New York 78-106
17. Chiu H.C., Jeng J.R., and Shieh S.M. Increased oxidizability of plasma low density lipoprotein from patients with coronary artery disease. Biochim. Biophys. Acta 1225 (1994) 200-208
18. Cominacini L., Garbin U., Pastorini A.M., Davoli A., Campagnola M., De Santis A., Pasini C., Faccini G.B., Trevisan M.T., Bertozzi L., Pasini F., and Lo Cascio V. Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis 99 (1993) 63-70
19. Cominacini L., Pastorino A.M., Garbin U., Campagnola M., Desantis A., Davoli A., Faccini G., Bertozzo L., Pasini F., Pasini A.F., and Locascio V. The susceptibility of low-density lipoprotein to in vitro oxidation is increased in hypercholesterolemic patients. Nutrition 10 (1994) 527-531
20. Croft K.D., Dimmitt S.B., Moulton C., and Lawrence J.B. Low density lipoprotein composition and oxidizability in coronary disease-apparent favourable effect of beta blockers. Atherosclerosis 97 (1992) 123-130
21. Cushing S.D., Berliner J.A., Valente A.J., Territo M.C., Navab M., Perhami R., Gerrity R., Schartz C.J., and Fogelman A.M. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sri. U.S.A. 87 (1990) 5134-5138
22. Daret D., Blin P., Dorian B., Rigaud M., and Larrue J. Synthesis of monohydroxylated fatty acids from linoleic acid by rat aortic smooth muscle cells and tisues: Influence on prostacyclin production. J. Lipid. Res. 34 (1993) 1473-1482
23. Demaio S.J., King III S.B., Lembo N.J., Roubin G.S., Hearn J.A., Bhagavan H.N., and Sgoutas D.S. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA). J. Am. Coll. Nutr. 11 (1992) 131-138
24. De Rijke Y.B., Vogelezang C.J.M., Van Berkel T.J., Princen H.M., Verwey H.F., Van Der Laarse A., and Bruschke A.V.G. Susceptibility of low-density lipoproteins to oxidation in coronary bypass patients. Lancet 340 (1992) 858-859
25. Dieber-Rotheneder M., Puhl H., Waeg G., Striegl G., and Esterbauer H. Effects of oral supplementation with d-alpha-tocopherol on the vitamin E content of human low density lipoproteins and its oxidation resistance. J. Lipid Res. 8 (1991) 1325-1332
26. Diplock A.T., Machlin L.J., Packer L., and Pryor W.A. Vitamin E: Biochemistry and health implications. Ann. N.Y. Acad. Sci. (1989) 570
27. Drake T.A., Hannani K., Fei H., Lavi S., and Berliner J.A. Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells. Am. J. Pathol. 138 (1991) 601-607
28. Duell P.B. The role of dietary antioxidants in prevention of atherosclerosis. Endocrinologist 5 (1995) 347-356
29. Enstrom J.E., Kanim L.E., and Klein M.A. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 3 (1992) 194-202
30. Esterbauer H., Gebicki J., Puhl H., and Juergens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad. Bio. Med. 13 (1992) 341-390
31. ++ mediated oxidation of LDL. In: Bellomo G., Finardi G., Maggi E., and Rice-Evans C. (Eds). "Free Radicals, Lipoprotein Oxidation and Atherosclerosis" (1995), Richelieu Press, London 11-26
32. Esterbauer H., and Juergens G. Mechanistic and genetic aspects of susceptibility of LDL to oxidation. Curr. Opin. Lipidol. 4 (1993) 114-124
33. Esterbauer H., Puhl H., Waeg G., Krebs A., and Dieber-Rotheneder M. The role of vitamin E in lipoprotein oxidation. In: Packer L., and Fuchs J. (Eds). "Vitamin E in Health and Disease" (1993), Dekker, New York 649-671
34. Esterbauer H., and Ramos P. Chemistry and pathophysiology of oxidaton of LDL. Rev. Physiol. Biochem. Pharmacol. 127 (1995) 31-64
35. Farrell P.M. Deficiency states, pharmacological effects, and nutrient requirements. In: Machlin L.J. (Ed). "Vitamin E: A Comprehensive Treatise" (1980), Dekker, New York 520-620
36. Fox P.L., Chisolm G.M., and Dicorleto P.E. Lipoprotein-mediated inhibition of endothelial cell production of platelet-derived growth factor-like protein depends on free radical lipid peroxidation. J. Biol. Chem. 262 (1987) 6046-6054
37. Frei B., and Gaziano J.M. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation. J. Lipid Res. 34 (1993) 2135-2145
38. Frostegard J., Wu R., Giscombe R., Holm G., Lefvert A.K., and Nilsson J. Induction of T-cell activation by oxidized low density lipoproteins. Arterioscler. Thromb. 12 (1992) 461-467
39. Gaziano J.M., Manson J.E., Branch L.G., Lamott F., Colditz G.A., Buring J.E., and Hennekens C.H. Dietary beta carotene and decreased cardiovascular mortality in an elderly cohort. J. Am. Coll. Cardiol. 19 (1992) 377
40. Gaziano J.M., Manson J.E., and Hennekens C.H. Natural antioxidants and cardiovascular disease: Observational epidemiologic studies and randomized trials. In: Frei B. (Ed). "Natural Antioxidants in Human Health and Disease" (1994), Academic Press, San Diego 387-409
41. Gaziano J.M., Manson J.E., Ridker P.M., Buring J.E., and Hennekens C.H. Beta carotene therapy for chronic stable angina. Circulation 82 Suppl. III (1990) 202
42. Gebicki J., Juergens G., and Esterbauer H. Oxidation of low density lipoprotein in vitro. In: Sies H. (Ed). "Oxidative stress" (1991), Academic Press, London 371-397
43. Gey K.F. Epidemiological correlations between poor plasma Ievels of essential antioxidants and the risk of coronary heart disease and cancer. In: Ong A.S.H., and Packer L. (Eds). "Lipid-Soluble Antioxidants: Biochemistry and Clinical Applications" (1992), Birkhluser Verlag, Basel 442-456
44. Gey K.F. Vitamin E and other essential antioxidants regarding coronary heart disease: Risk assessment studies. In: Packer L., and Fuchs J. (Eds). "Vitamin E in Health and Disease" (1993), Dekker, New York 589-633
45. Gey K.F. Prevention of early stages of cardiovascular disease and cancer may require concurrent optimization of all major antioxidants and other nutrients: An update and reevaluation of observational data and intervention trials. In: Bellome G., Magi E., and Rice-Evans C. (Eds). "Free Radicals, Lipoprotein Oxidation and Atherosclerosis" (1995), Richelieu Press, London
46. Gey K.F., and Puska P. Plasma vitamin E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology. Ann. N.Y. Acad. Sci. 570 (1989) 254-282
47. Gey K.F., Puska P., Jordan P., and Moser U.K. Inverse correlating between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am. J. Clin. Nutr. 53 (1991) 326S-334S
48. Gey K.F., Stahelin H.B., and Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Prospective Basel Study. Clin. Invest. 71 (1993) 3-6
49. Gillilan R.E., Mandell B., and Warbasse J.R. Quantitative evaluation of vitamin E in the treatment of angina pectoris. Am. Heart J. 93 (1977) 444-449
50. Haberland M.E., Fong D., and Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 241 (1988) 215-218
51. Haberland M.E., and Steinbrecher U.P. Modified low-density lipoproteins: Diversity and biological relevance in atherogenesis. In: Lusis A.J., Rotter J.I., and Sparks R.S. (Eds). "Molecular Genetics of Coronary Artery disease: Candidate Genes and Processes in Atherosclerosis" (1992), Monogr. Hum. Genet. 14 35-61
52. Halliwell B. Oxidation of low-density lipoproteins: Questions of initiation, propagation, and the effect of antioxidants. Am. J. Clin. Nutr. 61 (1995) 670S-677S
53. Hamilton T.A., Ma G.P., and Chisolm G.M. Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-alpha mRNA in stimulated murine peritoneal macrophages. J. Immunol. 144 (1990) 2343-2350
54. Harris P.L., Hardenbrock E.G., Dean F.P., Cusack E.R., and Jensen J.L. Blood tocopherol values in normal human adults and incidence of vitamin E deficiency. Proc. Soc. Exp. Biol. Med. 107 (1961) 381-383
55. Henriksen T., Mahoney E.M., and Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptors for acetylated low density lipoproteins. Proc. Natl. Acad. Sci. U.S.A. 78 (1981) 6499-6503
56. Heseker H., Schneider R., Moch K.J., Kohlmeier M., and Kübler W. Vitaminversorgung Erwachsener in der Bundesrepublik Deutschland. "VERA-Schriftenreihe Band IV" (1994), Wissenschaftlicher Fachverlag Dr. Fleck.
57. Hoffmann R.M., and Garewal H.S. Antioxidants and the prevention of coronary heart disease. Arch. Intern. Med. 155 (1995) 241-246
58. Jialal I., Fuller C.J., and Huet B.A. The effect of α-tocopherol supplementation on LDL oxidation: A dose-response study. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 190-198
59. Jialal I., and Grundy S.M. Effect of combined supplementation with α-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation. Circulation 88 (1993) 2780-2786
60. Juergens G., Chen Q., Esterbauer H., Mair S., Ledinski G., and Dinges H.P. Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein (a). Arterioscl. Thromb. 13 (1993) 1689-1699
61. Kardinaal A.F.M., Kok F.J., Ringstad J., Gomez-Aracena J., Mazaev V.P., Kohlmeier L., Martin B.C., Aro A., Kark J.D., Delgado-Rodriguez M., Riemersma R.A., Huttunen J.K., and Martin-Moreno J.M. Antioxidants in adipose tissue and risk of myocardial infarction: The EURAMIC study. Lancet 342 (1993) 1379-1384
62. Keaney Jr. J.F., and Frei B. Antioxidant protection of low-density lipoprotein and its role in the prevention of atherosclerotic vascular disease. In: Frei B. (Ed). "Natural Antioxidants in Human Health and Disease" (1994), Academic Press, San Diego 303-357
63. Keidar S., Kaplan M., Shapira C., Brook J.G., and Aviram M. Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: A possible role for angiotensin II. Atherosclerosis 107 (1994) 71-84
64. Kim J.A., Territo M.C., Wayner E., Carlos T.M., Parhami F., Smith C.W., Haberland M.W., Fogelman A.M., and Berliner J.A. Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL. Arterioscler. Thromb. 14 (1994) 427-433
65. Knekt P., Aromaa A., Maatela J., et al. Serum vitamin E, serum selenium and the risk of gastrointestinal cancer. Int. J. Cancer 42 (1988) 846-850
66. Knekt P., Reunanen A., Jarvinen R., Seppanen R., Heliövaara M., and Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am. J. Epidemiol. 139 (1994) 1180-1189
67. Krauss R.M. Low-density lipoprotein subclasses and risk of coronary artery disease. Curr. Opin. Lipidol. 2 (1991) 248-252
68. Kühn H., Belkner J., Wiesner R., Schewe T., Lakin V.Z., and Tikhaze A.K. Structure elucidation of oxygenated lipids in human atherosclerotic lesions. Eicosanoids 5 (1992) 17-22
69. Kühn H., Belkner J., Zaiss S., Fährenklemper T., and Wohlfeil S. Involvement of 15-lipoxygenase in early stages of atherogenesis. J. Exp. Med. 179 (1994) 1903-1911
70. Kugiyama K., Sakamoto T., Misumi I., Sugiyama S., Ohgushi M., Ogawa H., Horiguchi M., and Yasue H. Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells. Circ. Res. 73 (1993) 335-343
71. Lapidus L., Anderson H., Bengtson C., and Bosceus I. Dietary habits in relation to incidence of cardiovascular disease and death in women, a 12 year follow-up of participants in the study of women in Gothenberg, Sweden. Am. J. Clin. Nutr. 44 (1986) 444-448
72. 2+-catalysed oxidation. Biochem. J. 314 (1996) 577-585
73. Lehr H.A., Hübner C., Finckh G., Angermtiller S., Nolte D., Beisiegel U., Kohschtitter A., and Messmer K. Role of leukotrienes in leukocyte adhesion following systemic administration of oxidatively modified human low density lipoprotein in hamsters. J. Clin. Invest. 88 (1991) 9-14
74. Liao F., Berliner J.A., Mehrabian M., Navab M., Demer L.L., Lusis A.J., and Fogelman A.M. Minimally modified low density lipoprotein is biologically active in vivo in mice. J. Clin. Invest. 87 (1991) 2253-2257
75. Lynch S.M., and Frei B. Antioxidants as antiatherogens: Animal studies. In: Frei B. (Ed). "Natural Antioxidants in Human Health and Disease" (1994), Academic Press, San Diego 353-385
76. In: Machlin L.J. (Ed). "Vitamin E: A Comprehensive Treatise" (1980), Dekker, New York
77. Machlin L.J. Vitamin E. In: Machlin L.J. (Ed). "Handbook of Vitamins" (1991), Dekker, New York 99-144
78. Maggi E., Belazzi R., Falaschi F., Frattoni A., Perani G., Finardi G., Gazo A., Nai M., Romanini D., and Bellomo G. Enhanced LDL oxidation in uremic patients-an additional mechanism for accelerated atherosclerosis. Kidney Int. 45 (1994) 876-883
79. Maggi E., Chiesa R., Melissani G., Castellani R., Astore D., Grossi A., Finardi G., and Bellomo G. LDL oxidation in patients with severe carotid atherosclerosis: A study of in vitro and in vivo oxidation markers. Arterioscler. Thromb. 14 (1994) 1892-1899
80. Maggi E., Marchesi E., Ravetta V., Falaschi F., Finardi G., and Bellomo G. Low-density lipoprotein oxidation in essential hypertension. J. Hyperten. 11 (1993) 1103-1111
81. Malden L.T., Chait A., Raines E.W., and Ross R. The influence of oxidatively modified low density lipoproteins on expression of platelet-derived growth factor by human monocyte-derived macrophages. J. Biol. Chem. 266 (1991) 13901-13907
82. Mohr D., Bowry V.W., and Stocker R. Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation. Biochim. Biophys. Acta 1126 (1992) 247-254
83. Morel D.W., Dicorlet P.E., and Chisolm G.M. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Atherosclerosis 4 (1984) 357-364
84. Morel D.W., Hessler J.R., and Chisolm G.M. Low density of lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J. Lipid Res. 24 (1983) 1070-1076
85. Morris D.L., Kritchevsky S.B., and Davis C.E. Serum carotenoids and coronary heart disease; The lipid research clinics coronary primary prevention trial and follow-up study. J. Am. Med. Assoc. 272 (1994) 1439-1441
86. Nomura A.M., Stemmermann G.N., Heilbrun L.K., et al. Serum vitamin levels and the risk of cancer of specific sites in men of Japanese ancestry in Hawaii. Cancer Res. 45 (1985) 2369-2372
87. Navab M., Fogelman A.M., Berliner J.A., Territo M.C., Demer L.L., Frank J.S., Watson A.D., Edwards P.A., and Lusis A.J. Pathogenesis of atherosclerosis. Am. J. Cardiol. 76 (1995) 18C-23C
88. O'Brien K.D., and Chair A. The biology of the artery wall in atherogenesis. Am. J. Med. Clin. Nutr. 78 (1994) 41-67
89. Ohgushi M., Kugiyama K., Fukunaga K., Murohara T., Sugiyama S., Miyamot E., and Yasue H. Protein kinase C inhibitors prevent impairment of endothelium-dependent relaxation by oxidatively modified LDL. Arterioscler. Thromb. 13 (1993) 1525-1532
90. Oliver M.F. Antioxidant nutrients, atherosclerosis, and coronary heart disease. Br. Heart J. 73 (1995) 299-301
91. Olmedilla B., Granado F., Blanco I., and Rojas-Hidalgo E. Seasonal and sex-related variations in six serum carotenoids, retinol, and a-tocopherol. Am. J. Clin. Nutr. 60 (1994) 106-110
92. In: Ong A.S.H., and Packer L. (Eds). "Lipid-Soluble Antioxidants: Biochemistry and Clinical Applications" (1992), Birkhäuser Verlag, Basel
93. In: Packer L., and Fuchs J. (Eds). "Vitamin E in Health and Disease" (1993), Dekker, New York
94. Palinski W., Rosenfeld M.E., Ylä-Herttuala S., Gurtner G.C., Socher S.S., Butler S.W., Parthasarathy S., Carew T.E., Steinberg D., and Witztum J.L. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 1372-1376
95. Panasenko O.M., and Sergienko V.I. Free-radical modification of blood lipoproteins and atherosclerosis. Biol. Med. 7 (1994) 323-364
96. In: Parthasarathy S. (Ed). "Modified Lipoproteins in the Pathogenesis of Atherosclerosis" (1994), CRC Press, Boca Raton, FL
97. Princen H.M.G., Van Poppel G., Vogelezang C., Buytenhek R., and Kok F.J. Supplementation with vitamin E but no β-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Arterioscler. Thromb. 12 (1992) 554-562
98. Puhl H., Waeg G., and Esterbauer H. Methods to determine oxidation of low-density lipoproteins. Methods Enzymol. 233 (1994) 425-441
99. Quinn M.T., Parthasarathy S., Fong L.G., and Steinberg D. Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 2995-2998
100. Raal F.J., Areias A.J., and Joffe B.I. Low density lipoproteins and atherosclerosis-quantity or quality?. Redox Rep. 1 (1995) 171-176
101. Rajavashisth T.B., Andalibi A., Territo M.C., Berliner J.A., Navab M., Fogelman A.M., and Lusis A.J. Induction of endothelial cell expression of granulocyte and macropage colonystirnulating factors by modified low-density lipoproteins. Nature 344 (1990) 254-257
102. Reaven P.D., Grasse B.J., and Tribble D.L. Effects of linoleate-enriched and oleate-enriched diets in combination with α-tocopherol on the subfractions to oxidative modification in humans. Arterioscler. Thromb. 14 (1994) 557-566
103. Reaven P.D., Khouw A., Beltz W.F., Parthasarathy S., and Witztum J.L. Effect of dietary antioxidant combinations in humans. Arterioscler. Thromb. 13 (1993) 590-600
104. Regnström J., Nilsson J., Tornvall P., Landou C., and Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 339 (1992) 1183-1186
105. In: Rice-Evans C., and Bruckendorfer K.R. (Eds). "Oxidative Stress, Lipoproteins and Cardiovascular Dysfunction" (1995), Portland Press
106. Riemersma R.A., Wood D.A., Macintyre C.H.H., Elton R.A., Gey K.F., and Oliver M.F. Risk of angina pectoris and plasma concentrations of vitamins A, C, E and carotene. Lancet 337 (1991) 1-5
107. Rifici V.A., and Khachadurian A.K. Dietary supplementation with vitamins C and E inhibits in vitro oxidation of lipoproteins. J. Am. Col. Nutr. 12 (1993) 631-637
108. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., and Willett W.C. Dietary intake and risk of coronary heart disease among men. N. Engl. J. Med. 328 (1993) 1450-1456
109. Rosenfeld M.E., Palinski W., Yk-Herttuala S., Butler S., and Witztum J.L. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying servity from WHHL rabbits. Atherosclerosis 10 (1990) 336-349
110. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362 (1993) 801-809
111. Sasahara M., Raines E.W., Chait A., Carew T.E., Steinberg D., Wahl P.W., and Ross R. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. J. Clin. Invest. 94 (1994) 155-164
112. Schectman G., Byrd J.C., and Gruchow H.W. The influence of smoking on vitamin C status in adults. Am. J. Public Health 79 (1989) 158-162
113. Schmidt K., Graier W.F., Kostner G.M., Mayer B., and Kukovetz W.R. Activation of soluble guanylate cyclase by nitrovasodilators is inhibited by oxidized low-density lipoprotein. Biochem. Biopbys. Res. Commun. 172 (1990) 614-619
114. Schmidt R., Fazekas F., Hayn M., Kapeller P., Schmidt H., Kostner G.M., Lechner H., and Esterbauer H. Prevalence and risk factors for silent ischemic brain damage (SIBD) on MRI: The Austrian Stroke Prevention Study. Neurology 46 (1996) A288
115. Schmidt R., Hayn M., Fazekas F., Kapeller P., Eber B., Lechner H., and Esterbauer H. Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals: Correlations with plasma concentrations of naturally occurring antioxidants. Stroke (1996) (in press)
116. Schmidt R., Lechner H., Fazekas F., Niederkorn K., Reinhart B., Grieshofer P., Homer S., Offenbacher H., Koch M., Eber B., Schumacher M., Kapeller O., Freidl W., and Dusek T. Assessment of cerebrovascular risk profiles in healthy persons: Definition of research goals and the Austrian Stroke Prevention Study (ASPS). Neuroepidemiology 13 (1994) 308-313
117. Schober S.E., Comstock G.W., Helsing K.J., et al. Serologic precursors of cancer. I. Prediagnostic serum nutrients and colon cancer risk. Am. J. Epidemiol. 126 (1987) 1033-1041
118. Schwartz C.J., and Valente A.J. The pathogenesis of atherosclerosis. In: Frei B. (Ed). "Natural Antioxidants in Human Health and Disease" (1994), Academic Press, San Diego 287-302
119. Sowell A.L., Huff D.L., Yeager P.R., Caudill S.P., and Gunter E.W. Retinol, α-tocopherol, lutein/zeaxanthin, β-cryptoxanthin, lycopene, α-carotene, trans-β-carotene, and four retinyl esters in serum determined simultaneously by reversed-phase HPLC with multiwavelength detection. Clin. Chem. 40 (1994) 411-416
120. Stahelin H.B., Rösel F., Buess E., Brubacher G., et al. Cancer, vitamins, and plasma lipids: Prospective Basel study. J. Natl. Cancer Inst. 73 (1984) 1463-1468
121. Stalenhoef A.F.H., Defesche J.C., Kleinveld H.A., Demacker P.N.M., and Kastelein J.J.P. Decreased resistance against in vitro oxidation of LDL from patients with familial defective apolipoprotein B-100. Arterioscler. Thromb. 14 (1994) 489-493
122. Stampfer M.J., Hennekens C.H., Manson J.E., Colditz G.A., Rosner B., and Willett W.C. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 328 (1993) 1444-1449
123. Steinberg D. Clinical trials of antioxidants in atherosclerosis: Are we doing the right thing?. Lancet 346 (1995) 36-38
124. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., and Witztum J.S. Beyond cholesterol: Modifications of low density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320 (1989) 915-924
125. Steinberg D., and workshop participants. Antioxidants in the prevention of human atherosclerosis: Summary of the proceedings of a national heart, lung, and blood institute workshop: September 5-6, 1991, Bethesda, Maryland. Circulation 85 (1992) 2338-2344
126. Steinbrecher U.P., Parthasarathy S., Leake D.S., Witztum J.L., and Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 3883-3887
127. Stiko-Rahm A., Hultegardh-Nilsson A., Regnstrom J., Hamsten A., and Nilsson J. Native and oxidized LDL enhances production of PDGF AA and surface expression of PDGF receptors in cultured human smooth muscle cells. Arterioscler. Thromb. 12 (1992) 1099-1109
128. Street D.A., Comstock G.W., Salkfeld R.M., Schuep W., and Klag M. A population based case-control study of serum antioxidants and myocardial infarction. Am. J. Epidemiol. 134 (1991) 719-720
129. Street D.A., Comstock G.W., Salkeld R.M., Schüep W., and Klag M.J. Serum antioxidants and myocardial infarction: Are low levels of carotenoids and α-tocopherol risk factors for myocardial infarction?. Circulation 90 (1994) 1154-1161
130. Stocker R., Bowry V.W., and Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does a-tocopherol. Proc. Natl. Acad. Sci. U.S.A. 38 (1991) 1646-1650
131. Tatzber G., and Esterbauer H. Autoantibodies to oxidized low-density lipoprotein. In: Bellomo G., Finardi G., Maggi E., and Rice-Evans C. (Eds). "Free Radicals, Lipoprotein Oxidation and Atherosclerosis" (1995), Richelieu Press, London 245-259
132. Terkeltaub R., Banka C.L., Solan J., Santoro D., Brand K., and Curtiss L.K. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arterioscler. Thromb. 14 (1994) 47-53
133. Thomas C.E., Jackson R.L., Ohweiler D.F., and Ku G. Multiple lipid oxidation products in low-density lipoproteins induce interleukin-1 beta release from human blood mononuclear cells. J. Lipid. Res. 35 (1994) 417-427
134. Tribble D.L., Holl L.G., Wood P.D., and Krauss R.M. Variations in oxidative susceptibility among 6 low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 93 (1992) 189-199
135. Tribble D.L., Vandenberg J.J.M., Motchnik P.A., Ames B.N., Lewis D.M., Chait A., and Krauss R.M. Oxidative susceptibility of low-density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 1183-1187
136. Van Poppel G., Kardinaal A., Princen H., and Kok F.J. Antioxidants and coronary heart disease. Ann. Med. 26 (1994) 429-434
137. Vollset S.E., and Bjelke E. Does consumption of fruit and vegetables protect against stroke?. Lancet 2 (1983) 742
138. Waeg G., Puhl H., and Esterbauer H. LDL oxidation: Results and relevance for atherogenesis and possible clinical consequences. Fat. Sci. Technol. 96 (1994) 20-22
139. Wald N.J., Thompson S.G., Densem J.W., et al. Serum vitamin E and subsequent risk of cancer. Br. J. Cancer 56 (1987) 69-72
140. Weis J.R., Pitas R.E., Wilson B.D., and Rodgers G.M. Oxidized low-density lipoprotein increases cultured human endothelial cell tissue factor activity and reduces protein C activation. FASEB J. 5 (1991) 2459-2465
141. World Health Organization (WHO). World Health Statistics (1991), Annual. Genova
142. Winkelhofer-Roob B.M., Puhl H., Khoschsurur G., Vant Hof M.A., Esterbauer H., and Shmerling D.H. Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during čtene supplementation in cystic fibrosis. Free Rad. Bio. Med. 18 (1995) 849-859
143. Witztum J.L. The oxidation hypothesis of atherosclerosis. Lancet 344 (1994) 793-795
144. Yamaguchi M., Sato H., and Bannai S. Induction of stress proteins in mouse peritoneal macrophages by oxidized low density lipoprotein. Biochem. Biopbys. Res. Commun. 193 (1993) 118-1201
145. Ylä-Herttuala S., Rosenfeld M.E., Parthasarathy S., Glass C.K., Sigal E., Särkioja T., Witztum J.L., and Steinberg D. Gene expression in macrophage-rich human atherosclerotic lesions: 15-Lypoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J. Clin. Invest. 87 (1991) 1146-1152
146. Ylä-Herttuala S., Rosenfeld M.E., Parthasarathy S., Glass C.K., Sigal E., Witztum J.L., and Steinberg D. Colocalization of 15-lipoxygenase mRNA and protein with isotopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 6959-6963
147. Zhang H., Basra H.J.K., and Steinbrecher U.P. Effects of oxidatively modified LDL on cholesterol esterification in cultured macrophages. J. Lipid Res. 31 (1990) 1361-1369
148. Zieden B., Molgaard J., and Olsson A. Low-density lipoprotein oxidation and coronary atherosclerosis. Lancet 340 (1992) 727-728
149. Ziouzenkova O., Gieseg S.P., Ramos P., and Esterbauer H. Factors affecting resistance of LDL to oxidation. Lipids 31 (1996) 571-576
150. Zwijsen R.M.L., Japenga S.C., Heijen A.M.P., Van Den Bos R.C., and Koeman J.H. Induction of plateiet-derived growth factor chain a gene expression in human smooth muscle cell by oxidized low density lipoproteins. Biochem. Biopbys. Res. Commun. 186 (1992) 1410-1416